J7508 HCPCS Level II code: Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg
J7508 is the HCPCS code for “Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J7508Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg
Short description: Tacrol astagraf ex rel oral
HCPCS · United States
Medicare details
The indicators CMS publishes with J7508 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care; Immunosuppressive drugs
- BETOS category
- Other drugs
- Added
- Jan 1, 2014
Where J7508 sits
- 1J codesDrugs administered other than orally
- 2Active code J7508Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J7508 mean?
J7508 is the HCPCS code for “Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J7508?
CMS lists J7508’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J7508
All J codesJ7502Cyclosporine, oral, 100 mgJ7503Tacrolimus, extended release, (envarsus xr), oral, 0.25 mgJ7504Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mgJ7505Muromonab-cd3, parenteral, 5 mgJ7506Prednisone, oral, per 5 mgJ7507Tacrolimus, immediate release, oral, 1 mgJ7509Methylprednisolone oral, per 4 mgJ7510Prednisolone oral, per 5 mgJ7511Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mgJ7512Prednisone, immediate release or delayed release, oral, 1 mgJ7513Daclizumab, parenteral, 25 mgJ7514Mycophenolate mofetil (myhibbin), oral suspension, 100 mg